Breast Cancer Screening Market Examined in New Research Report

Comments · 346 Views

Breast Cancer Screening Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Test Type (Blood Marker tests, Imaging Test, Genetic Test, Immunohistochemistry Test); End User (Hospitals, Diagnostic Centers, Cancer Institutes, Research Laboratories), and Geography

The Breast Cancer Screening Market is expected to reach US$ 6,209.25 Mn by 2027 from US$ 4,638.63 Mn in 2019; it is estimated to grow at a CAGR of 4.8% from 2020 to 2027.

Breast cancer screening  tests are performed with an aim to analyze the screening of breast cancer. The screening procedure identifies the early signs of cancer, even before the symptoms begin to show. The foremost goal of screening is to detect disease at its earliest and most treatable stage.

Get Sample PDF:

https://www.theinsightpartners.com/sample/TIPRE00009796/

 

Breast cancer screening plays a significant role in determining the suitable treatment procedure, along with the pace required for the same. Early detection can help in reducing the mortality rates of cancer; hence, medical professionals, market players as well as government authorities are implementing new diagnostics and treatment facilities. Thus, the rise in investments and better reimbursement policies favor the growth of the breast cancer screening market. In October 2019, the Breast Cancer Research Foundation (BCRF) announced US$ 66 million to fund breast cancer research for the year 2019–2020. This grant is meant to support the work of ~275 scientists at leading medical institutions and academics around the world. Additionally, according to the BCRF, research studies on breast cancer have led to 40% dip in the deaths associated with the disease. Moreover, as per the American Recovery and Reinvestment Act of 2009 (ARRA), its funding is sponsoring research to understand and address the causes of cancer health inequalities. For instance, the Howard University Cancer Center and Johns Hopkins University Cancer Center have extended their partnership to carry research on cancer screening, diagnosis, treatment, prevention, and supportive care, with a particular focus on cancer incidence among African-Americans. 

Buy Now: https://www.theinsightpartners.com/sample/TIPRE00009796/

 

The report analyzes the breast cancer screening market segmented on the basis of the following segments:

Breast Cancer Screening Market – By Test Type

  • Blood Marker Test
  • Imaging Test
  • Genetic Test
  • Immunohistochemistry Test

Breast Cancer Screening Market – By End-User

  • Diagnostic Centers
  • Hospitals
  • Research Laboratories
  • Cancer Institutes

Breast Cancer Screening Market– By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • K
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East Africa (MEA)
    • Saudi Arabia
    • A.E
    • South Africa
  • South Central America (SCAM)
    • Brazil
    • Argentina

 

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

Comments